Literature DB >> 28153842

Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.

Stefan F C Vaessen1, Marola M H van Lipzig1, Raymond H H Pieters1, Cyrille A M Krul1, Heleen M Wortelboer1, Evita van de Steeg2.   

Abstract

Intestinal transporter proteins and metabolizing enzymes play a crucial role in the oral absorption of a wide variety of drugs. The aim of the current study was to characterize better available intestinal in vitro models by comparing expression levels of these proteins and enzymes between porcine intestine, human intestine, and Caco-2 cells. We therefore determined the absolute protein expression of 19 drug transporters and the mRNA expression of 12 metabolic enzymes along the pig intestinal tract (duodenum, jejunum, ileum; N = 4), in human intestine (jejunum; N = 9), and Caco-2 cells. Expression of the included transporters and enzymes was in general well comparable between porcine and human intestinal tissue, although breast cancer resistance protein, monocarboxylate transporter 5, multidrug resistance protein (MRP) 1, MRP1, MRP3 (∼2-fold), and organic anion-transporting polypeptide (OATP) 4A1 (∼6-fold) was higher expressed in pig compared with human jejunum. Alternatively, expression level of relevant transporter proteins (glucose transporter 1, OATP4A1, MRP2, MRP1, and OATP2B1) was significantly higher (3- to 130-fold) in Caco-2 cells compared with human jejunum. Moreover, all examined CYPs showed at least a fivefold lower gene expression in Caco-2 cells compared with human jejunum, with the smallest differences for CYP1A1 and CYP3A5 and the largest difference for CYP3A4 (871-fold higher expression in human jejunum compared with Caco-2 cells). In conclusion, a comprehensive overview is provided of the expression levels of clinically relevant transporter proteins and metabolic enzymes in porcine and human intestinal tissue and Caco-2 cells, which may assist in deciding upon the most suitable model to further improve our understanding of processes that determine intestinal absorption of compounds.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28153842     DOI: 10.1124/dmd.116.072231

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

Review 1.  Porcine cytochrome P450 3A: current status on expression and regulation.

Authors:  Martin Krøyer Rasmussen
Journal:  Arch Toxicol       Date:  2020-03-14       Impact factor: 5.153

2.  Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.

Authors:  Ondrej Martinec; Martin Huliciak; Frantisek Staud; Filip Cecka; Ivan Vokral; Lukas Cerveny
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied.

Authors:  Chang-Shun Liu; Xiao-Ying Long; Jing-Yi Ye; Zhong-Yun Chen; Chuan-Li Huang; Bei Huang; Yu-Rong Zheng; Ying-Feng Zhang; Ban-Yi Lu; Lin He
Journal:  Int J Nanomedicine       Date:  2020-08-26

Review 4.  Organoid technologies for the study of intestinal microbiota-host interactions.

Authors:  Valentina Bozzetti; Stefania Senger
Journal:  Trends Mol Med       Date:  2022-02-26       Impact factor: 11.951

Review 5.  Gutsy science: In vitro systems of the human intestine to model oral drug disposition.

Authors:  Christopher M Arian; Tomoki Imaoka; Jade Yang; Edward J Kelly; Kenneth E Thummel
Journal:  Pharmacol Ther       Date:  2021-08-31       Impact factor: 12.310

Review 6.  Mechanisms and the clinical relevance of complex drug-drug interactions.

Authors:  Arthur G Roberts; Morgan E Gibbs
Journal:  Clin Pharmacol       Date:  2018-09-27

7.  Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linking.

Authors:  Jennifer E Speer; Dulan B Gunasekara; Yuli Wang; John K Fallon; Peter J Attayek; Philip C Smith; Christopher E Sims; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-04-27       Impact factor: 4.355

8.  Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.

Authors:  Jennifer E Speer; Yuli Wang; John K Fallon; Philip C Smith; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-11-04       Impact factor: 4.355

9.  Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.

Authors:  Albert P Li; Ming-Chih D Ho; Novera Alam; Walter Mitchell; Susan Wong; Zhengyin Yan; Jane R Kenny; Cornelis E C A Hop
Journal:  Pharmacol Res Perspect       Date:  2020-10

10.  Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.

Authors:  Yvonne E Arnold; Yogeshvar N Kalia
Journal:  Biomedicines       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.